Drug Profile
Aspirin/omeprazole 650/20
Alternative Names: Aspirin/omeprazole 650mg/20mg; OA-65020; Omeprazole/aspirin 20/650; PA-65020Latest Information Update: 08 Feb 2019
Price :
$50
*
At a glance
- Originator POZEN
- Developer Old API Wind-down Ltd
- Class 2 pyridinylmethylsulfinylbenzimidazoles; Antiplatelets; Antipyretics; Antirheumatics; Antiulcers; Benzimidazoles; Cardiovascular therapies; Gastric antisecretories; Non-opioid analgesics; Salicylates; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Pain
Most Recent Events
- 06 Feb 2019 Aralez Pharmaceuticals is now called Old API Wind-down
- 04 Nov 2017 No recent reports of development identified for phase-I development in Pain in USA (PO, Tablet)
- 07 Dec 2012 Phase-I development is ongoing in USA